GGrantIndex
← Leaderboards

Edward A Botchwey

University Of Virginia

$8,169,626
Attributed
$9,636,081
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1M · FY200625
$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,636,081 · 8

By mechanism

R01$5,847,330 · 3
T32$1,922,135 · 1
R56$1,218,912 · 2
K01$634,704 · 1
R13$13,000 · 1

Top collaborators

Most similar at University Of Virginia

Same institution · by research overlap

Others in their field

Top investigators on “Signal Transduction

Research focus

Signal TransductionTissue EngineeringBaseCellsEndothelial CellsBiocompatible MaterialsResponseIn VivoGrowthTissuesScaffoldImplantBlood VesselsRattusIn VitroMicrospheresLife ExpectancyRegulationBone Healing3-DimensionalImplantationOsteogenesisKineticsDefect

Grant awards (28)

T32 CTEng (Cellular and Tissue Engineering) Training Program$481,905
T32 · FY2025 · GM
Artery biomechanics and vascular damage in sickle cell disease$548,686
R01 · FY2024 · HL · contact PI
T32 CTEng (Cellular and Tissue Engineering) Training Program$494,423
T32 · FY2024 · GM
Artery biomechanics and vascular damage in sickle cell disease$564,117
R01 · FY2023 · HL · contact PI
T32 CTEng (Cellular and Tissue Engineering) Training Program$477,482
T32 · FY2023 · GM
Artery biomechanics and vascular damage in sickle cell disease$580,863
R01 · FY2022 · HL · contact PI
T32 CTEng (Cellular and Tissue Engineering) Training Program$468,325
T32 · FY2022 · GM
Artery biomechanics and vascular damage in sickle cell disease$580,863
R01 · FY2021 · HL
Regenerative Immunotherapy using light triggered in vivo activation of adhesive peptides$429,912
R56 · FY2020 · DE · contact PI
Immune Modulatory Nanofibers for Skeletal Muscle Reconstruction$394,500
R56 · FY2018 · AR · contact PI
Immune Modulatory Nanofibers for Skeletal Muscle Reconstruction$394,500
R56 · FY2017 · AR · contact PI
2015 Biomaterials & Tissue Engineering Gordon Research Conference and Gordon Research Seminar$13,000
R13 · FY2015 · EB · contact PI
Phospholipid Growth Factors for Therapeutic Arteriogenesis and Tissue Engineering$272,337
R01 · FY2014 · AR · contact PI
Therapeutic S1P Drug Targets for Cranial Bone Repair$339,725
R01 · FY2013 · DE · contact PI
Phospholipid Growth Factors for Therapeutic Arteriogenesis and Tissue Engineering$277,895
R01 · FY2013 · AR · contact PI
Therapeutic S1P Drug Targets for Cranial Bone Repair$355,725
R01 · FY2012 · DE · contact PI
Phospholipid Growth Factors for Therapeutic Arteriogenesis and Tissue Engineering$292,521
R01 · FY2012 · AR · contact PI
Therapeutic S1P Drug Targets for Cranial Bone Repair$347,670
R01 · FY2011 · DE · contact PI
Phospholipid Growth Factors for Therapeutic Arteriogenesis and Tissue Engineering$309,676
R01 · FY2011 · AR · contact PI
Therapeutic S1P Drug Targets for Cranial Bone Repair$359,928
R01 · FY2010 · DE · contact PI
Phospholipid Growth Factors for Therapeutic Arteriogenesis and Tissue Engineering$323,933
R01 · FY2010 · AR · contact PI
Vascularized Bone Grafts for Tissue Engineering$128,401
K01 · FY2010 · AR · contact PI
Therapeutic S1P Drug Targets for Cranial Bone Repair$364,942
R01 · FY2009 · DE · contact PI
Phospholipid Growth Factors for Therapeutic Arteriogenesis and Tissue Engineering$328,449
R01 · FY2009 · AR · contact PI
Vascularized Bone Grafts for Tissue Engineering$127,650
K01 · FY2009 · AR · contact PI
Vascularized Bone Grafts for Tissue Engineering$126,919
K01 · FY2008 · AR · contact PI
Vascularized Bone Grafts for Tissue Engineering$126,211
K01 · FY2007 · AR · contact PI
Vascularized Bone Grafts for Tissue Engineering$125,523
K01 · FY2006 · AR · contact PI